• SENSEX 72,781.89
    -251.89 (--0.34%)
  • BANKNIFTY 55,316.00
    -165.05 (--0.30%)
  • JSW Steel
    1,158.95 1,072.90(%)
  • NSE
    1,780.00 1,878.00(%)
  • SS Retail
    828.30 888.00(%)
  • Infosys
    1,095.90 1,727.85(%)
  • T R I L
    360.95 495.80(%)
  • Max Healthcare
    850.10 843.00(%)
  • IndusInd Bank
    866.00 725.90(%)
  • Cholaman.Inv.&Fn
    1,553.00 1,299.80(%)
  • Life Insurance
    391.35 361.00(%)
  • Reliance Industries
    1,187.90 1,611.20(%)
  • Tata Elxsi
    3,706.00 5,949.95(%)
  • Meesho
    226.45 125.70(%)
  • Elecon Engg.Co
    501.05 579.95(%)
  • HDFC Bank
    708.00 682.00(%)
  • TCS
    2,335.45 3,336.70(%)
  • MV Electrosystems
    999.00 999.00(%)
  • Voltas
    1,050.75 1,582.00(%)
  • Go Digit General
    284.75 373.40(%)
  • Hero Motors
    167.50 179.00(%)
  • B H E L
    463.60 463.60(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Morepen Laboratories Ltd Pharmaceuticals - Indian - Bulk Drugs & Formln

  • Morepen
  • BSE Code : 2685.0
  • ISIN : INE083A01026
128.33 6 (5.00%)
  • As on 14 Oct 2026 (EOD)

  • Today’s Low

    117.50

  • Today’s High

    128.33

  • Open

    120.00

  • Perv Close

    122.22

  • 52W Low

    33.05

  • 52W High

    150.70

Key Indicators

  • P/E(TTM)

    62.98

  • Mar.Cap (₹Cr.)

    7,031.89

  • Div & Yield %

    0.16

  • Book Value(₹)

    22.68

  • Debt-Equity Ratio

    5.00

  • AGM Date

    14-Oct-2026

  • EPS

    2.03

  • P/E Ratio

    62.98

Financials Ratios

  • Debt-Equity Ratio

    0.03

  • Mar.Cap (₹Cr.)

    7,031.89

  • RONW (%)

    12.08

  • ROCE (%)

    16.12

Score Board

  • Equity (₹ in Cr.)

    109.59

  • BV (₹)

    22.70

  • Sales( ₹ in Cr.)

    1,681.20

  • NP (in Cr.)

    64.68

  • NP Var(%)

    -36.0

  • Div%

    10.0

  • CPS (₹)

    1.70

  • EPS (₹)

    1.20

  • Traded Value (₹ in Lakhs)

    7,005.59

  • 52 Week High

    150.70

  • 52 Week Low

    33.05

  • Price BSE

    128.0

  • Price NSE

    128.00

  • Market Capital( in Cr.)

    7,005.59

  • P/C Ratio

    74.60

  • P/E Ratio

    108.40

  • Price Vs.BV

    1.20

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2026 Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar
INCOME :            
Sales Turnover 1,681.20 1,554.54 1,537.59 1,338.88 1,449.27 1,112.42
Excise Duty 0.00 0.00 0.00 0.00 0.00 0.00
Net Sales 1,681.20 1,554.54 1,537.59 1,338.88 1,449.27 1,112.42
Other Income 22.59 15.72 12.57 5.76 10.24 11.77
Stock Adjustments -3.23 44.36 -5.13 -16.54 -1.74 41.98
Total Income 1,700.56 1,614.62 1,545.03 1,328.10 1,457.77 1,166.17
EXPENDITURE :            
Raw Materials 1,058.13 1,019.99 945.15 886.48 988.81 778.60
Power and Fuel Cost 44.90 40.62 34.09 23.78 18.93 13.00
Employee Cost 206.28 177.22 160.28 146.19 150.00 123.20
Other Manufacturing Expenses 76.80 68.03 44.19 33.81 23.39 13.57
Selling and Administration Expenses 148.10 118.39 163.47 111.62 87.90 82.36
Miscellaneous Expenses 31.68 21.23 23.47 43.19 49.36 31.30
Employee Benefit Expenses 206.28 177.22 160.28 146.19 150.00 123.20
Less: Preoperative Expenditure 0.00 0.00 0.00 0.00 0.00 0.00
Total Expenses 1,565.89 1,445.48 1,370.64 1,245.08 1,318.39 1,042.03
Operating Profit 134.67 169.13 174.39 83.03 139.37 124.15
Interest 16.10 7.10 3.51 1.98 -7.37 1.79
Gross Profit 118.57 162.03 170.88 81.05 146.74 122.36
Depreciation 29.31 24.44 21.90 18.01 21.19 28.11
Profit Before Tax 89.26 137.59 148.98 63.04 125.55 94.25
Current Tax 14.71 31.28 38.48 16.60 22.00 0.00
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax 8.49 4.73 -0.44 0.20 2.48 0.00
Reported Net Profit 66.06 101.58 110.94 46.24 101.06 94.25
Extraordinary Items 1.38 0.00 0.00 0.00 0.00 0.00
Adjusted Net Profit 64.68 101.58 110.94 46.24 101.06 94.25
Adjustment below Net Profit 0.00 0.00 0.00 0.00 0.00 0.00
P & L Balance brought forward 429.78 328.20 217.27 171.03 74.96 -19.29
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
Appropriations 10.86 0.00 0.00 0.00 5.00 0.00
P & L Balance carried down 484.98 429.78 328.20 217.27 171.03 74.96
Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Preference Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Equity Dividend (%) 10.00 10.00 0.00 0.00 0.00 0.00
Dividend Per Share(Rs) 0.20 0.20 0.00 0.00 0.00 0.00
Earnings Per Share-Unit Curr 1.21 1.85 2.17 0.90 2.12 2.10
Earnings Per Share(Adj)-Unit Curr 1.21 1.85 2.17 0.90 2.12 2.10
Book Value 22.68 21.56 17.39 15.26 11.97 8.92
Book Value(Adj)-Unit Curr 22.68 21.56 17.39 15.26 11.97 8.92

Shareholding Pattern

  • Promoter Group

    35.65%

  • Public Share Holding

    64.35%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 0 0.00 0 0
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 154,129,838 28.13 154,129,838 11
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 41,241,750 7.53 41,241,750 24
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 195,371,588 35.65 195,371,588 35
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 60,000 0.01 60,000 1
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 1,705,757 0.31 1,705,757 1
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 18,817,024 3.43 18,817,024 48
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 4,439,149 0.81 4,439,149 4
Mutual Funds / UTI 15,165 0.00 15,165 2
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 3,205,310 0.58 3,205,310 6
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 28,242,405 5.15 28,242,405 62
2] Non Institution
Bodies Corporate 17,874,079 3.26 17,240,708 848
Clearing Members 2,885,277 0.53 2,885,277 73
Directors of their Relatives 0 0.00 0 0
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 6,619,875 1.21 6,618,218 3,555
Foreign Non Institution Other 35,393,120 6.46 35,393,120 4
Hindu Undivided Families 0 0.00 0 0
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 41,362,705 7.55 36,544,810 140
Individuals holding nominal share capital up to Rs. 1 lakh 214,597,406 39.16 194,245,352 399,207
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 27,781 0.01 27,781 7
Others 0 0.00 0 0
Sub Total 324,339,706 59.19 298,534,729 403,835
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 547,953,699 100.00 522,148,722 403,932

Company Background

Morepen Laboratories LtdPharmaceuticals - Indian - Bulk Drugs & Formln

  • Morepen Laboratories Ltd
  • BSE Code : 2685.0
  • ISIN : INE083A01026

  • Incorporation Year

    1984

  • Registered Office

    Morepen Village
    Nalagarh Road Near Baddi, Solan,
    Himachal Pradesh-173205

  • Telephone

    91-01795-276201-03

  • FAX

    91-01795-276204

  • Chairman

    Sushil Suri

  • Managing Director

  • Company Secretary

    Vipul Kumar Srivastava

  • Auditor

    S P Babuta & Associates

  • Face Value

    2

  • Listing

    NSE

  • Registrar

    Mas Services Limited
    T-34 2nd Floor,
    Okhla Industrial Are,Phase II
    Mumbai - New Delhi - 110020

Morepen Laboratories Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Morepen Labs. 127.85 1,702.69 1,681.20 62.67 7.20
Abbott India 26,346.00 7,217.19 6,929.05 34.67 43.78
Astrazeneca Phar 5,943.50 2,304.07 2,275.58 87.60 27.86
Glaxosmi. Pharma 2,539.40 3,932.76 3,790.20 40.57 58.17
Novartis India 1,988.85 393.10 354.33 50.22 15.94
Cipla 1,312.85 20,102.60 18,979.95 34.50 13.88
Bliss GVS Pharma 661.10 773.53 729.81 61.44 12.51
Amrutanjan Healt 503.10 520.13 502.55 26.95 24.16
Fermenta Biotec. 499.90 474.15 450.25 23.34 18.77
Guj. Themis Bio. 392.05 168.25 165.82 104.83 18.05
Ambalal Sarabhai 38.95 19.52 3.94 72.13 6.77